|
|||||
|
|
Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia |
|
| Authors: | Adi J. Klil-Drori MD MSc Hui Yin MSc Laurent Azoulay PhD Alexa Del Corpo BSc Michaël Harnois MSc Michel-Olivier Gratton MSc Harold J. Olney MD Robert Delage MD Pierre Laneuville MD Luigina Mollica MD PhD Lambert Busque MD Sarit E. Assouline MD MSc for the Groupe Québécois de Recherche en Leucémie Myéloïde Chronique et Néoplasies Myéloprolifératives (GQR LMC-NMP) |
| Affiliation: | 1. Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada Department of Epidemiology, McGill University, Montreal, Quebec, Canada;2. Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada;3. Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada;4. Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada;5. Department of Hematology and Transfusion Medicine, University of Montreal Health Centre, Montreal, Quebec, Canada University of Montreal, Montreal, Quebec, Canada;6. University of Quebec Center of Hematology and Oncology, University of Quebec Health Centre, Quebec City, Quebec, Canada;7. Department of Epidemiology, McGill University, Montreal, Quebec, Canada;8. Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada University of Montreal, Montreal, Quebec, Canada;9. Department of Oncology, McGill University, Montreal, Quebec, Canada |
| Abstract: | |
| Keywords: | chronic myeloid leukemia (CML) drug monitoring epidemiology guideline adherence observational study |